Veterinary Medicines

Vacina Anti-rábica, suspensão injetável para cães, gatos e bovinos

Authorised
  • RABIES VIRUS (INACTIVATED) STRAIN FLURY LEP
Download as PDF

Product identification

Medicine name:
Vacina Anti-rábica, suspensão injetável para cães, gatos e bovinos
Active substance:
  • RABIES VIRUS (INACTIVATED) STRAIN FLURY LEP
Target species:
  • Dog
  • Cat
  • Cattle
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • RABIES VIRUS (INACTIVATED) STRAIN FLURY LEP
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
    • Cat
    • Cattle
      • Meat and offal, milk
        0
        day
  • Intramuscular use
    • Dog
    • Cat
    • Cattle
      • Meat and offal, milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Legal status of supply:
  • Medicinal product subject to medical prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Medinfar Serological Products And Equipment S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • CZ VETERINARIA, S.A.
Responsible authority:
  • DGAV
Authorisation number:
  • 622/98DGV
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 8/05/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."